ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,403Medicare Part D Prescriptions Filled, Including Refills

Rank: 278 out of 3593

$641K Total Retail Price of All Prescriptions

Rank: 371 out of 3593

863 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 863 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 11,032 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LISINOPRIL 647 487 1 2
OMEPRAZOLE 613 457 2 5
SIMVASTATIN 584 478 3 1
PRAVASTATIN SODIUM 511 353 4 13
LEVOTHYROXINE SODIUM 494 385 5 4
AMLODIPINE BESYLATE 475 427 6 3
METFORMIN HCL 423 319 7 6
GABAPENTIN 415 298 8 16
FENOFIBRATE 300 191 9 39
LOSARTAN POTASSIUM 292 254 10 14
METOPROLOL SUCCINATE 261 205 11 19
LOVASTATIN 257 227 12 20
HYDROCHLOROTHIAZIDE 250 203 13 10
ATENOLOL 246 210 14 11
ALENDRONATE SODIUM 236 199 15 22
FLUTICASONE PROPIONATE 235 149 16 32
CARVEDILOL 229 185 17 23
ZOLPIDEM TARTRATE 219 167 18 12
FUROSEMIDE 211 170 19 9
METOPROLOL TARTRATE 209 182 20 8
MELOXICAM 205 161 21 29
LISINOPRIL-HYDROCHLOROTHIAZIDE 195 152 22 26
CIPROFLOXACIN HCL 179 119 23 52
ATORVASTATIN CALCIUM 164 125 24 15
DONEPEZIL HCL 160 148 25 31
GLIPIZIDE 160 130 25 40
CLOPIDOGREL 156 125 27 30
LOSARTAN-HYDROCHLOROTHIAZIDE 153 139 28 48
GLIMEPIRIDE 152 130 29 44
LOVAZA 152 104 29 106
TRAMADOL HCL 144 86 31 17
RANITIDINE HCL 134 120 32 27
GLYBURIDE-METFORMIN HCL 106 71 R 33 95
LANTUS 104 68 34 57
MECLIZINE HCL 95 85 35 96
ENALAPRIL MALEATE 94 50 36 38
METFORMIN HCL ER 91 70 37 67
WARFARIN SODIUM 88 77 38 18
CITALOPRAM HBR 87 67 39 25
CLONIDINE HCL 87 82 39 41
VENTOLIN HFA 85 57 41 80
CLOTRIMAZOLE-BETAMETHASONE 80 53 42 94
PLAVIX 79 62 43 42
POTASSIUM CHLORIDE 79 69 43 24
TAMSULOSIN HCL 75 72 45 33
NAMENDA 73 72 46 50
ADVAIR DISKUS 71 47 47 47
DICLOFENAC SODIUM 70 60 48 74
NABUMETONE 69 32 49 251
IBUPROFEN 66 36 50 43
AMOX TR-POTASSIUM CLAVULANATE 63 49 51 138
DIOVAN 63 52 51 46
CRESTOR 61 52 53 21
HUMULIN 70-30 61 52 53 215
INSULIN SYRINGE 60 49 55 91
DIOVAN HCT 57 45 56 76
SERTRALINE HCL 56 38 57 28
BENAZEPRIL HCL 52 42 58 69
METHYLPREDNISOLONE 51 32 59 103
PANTOPRAZOLE SODIUM 51 41 59 45
GLYBURIDE 51 44 R 59 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 27, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.